Pacific Biosciences of California, Inc. Cost of Goods and Services Sold
Pacific Biosciences of California, Inc. (PACB) reported Cost of Goods and Services Sold of $15.50 million for the 3-month period ending 2022-06-30, per its 10-Q filed 2022-08-08.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfGoodsAndServicesSold · last filed 2022-08-08
- Pacific Biosciences of California, Inc. cost of goods and services sold for the quarter ending 2022-06-30 was $15.50M, a 17.22% increase year-over-year.
- Pacific Biosciences of California, Inc. cost of goods and services sold for the quarter ending 2022-03-31 was $14.82M, a 16.72% increase year-over-year.
- Pacific Biosciences of California, Inc. cost of goods and services sold for the quarter ending 2021-09-30 was $19.52M, a 62.45% increase year-over-year.
- Pacific Biosciences of California, Inc. cost of goods and services sold for the quarter ending 2021-06-30 was $13.22M, a 26.36% increase year-over-year.
- Pacific Biosciences of California, Inc. cost of goods and services sold for fiscal 2020 was $46.33M, a 17.74% decline from fiscal 2019.
- Pacific Biosciences of California, Inc. cost of goods and services sold for fiscal 2019 was $56.31M, a 5.20% increase from fiscal 2018.
- Pacific Biosciences of California, Inc. cost of goods and services sold for fiscal 2018 was $53.53M, a 8.98% decline from fiscal 2017.
- Pacific Biosciences of California, Inc. cost of goods and services sold for fiscal 2017 was $58.81M, a 26.32% increase from fiscal 2016.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 3 month as first filed | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 6 month as first filed | Cost of Goods and Services Sold 9 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|---|---|---|
| 2022-06-30 | $15.50M 10-Q · filed 2022-08-08 | $30.32M 10-Q · filed 2022-08-08 | ||||
| 2022-03-31 | $14.82M 10-Q · filed 2022-05-06 | |||||
| 2021-09-30 | $19.52M 10-Q · filed 2021-11-05 | $32.74M derived: sum of 2 quarters · filed 2022-08-08 | $52.40M 10-Q · filed 2021-11-05 | $61.18M derived: sum of 4 quarters · filed 2022-08-08 | ||
| 2021-06-30 | $13.22M 10-Q · filed 2022-08-08 | $16.86M 10-Q · filed 2021-08-06 | $25.92M 10-Q · filed 2022-08-08 | $32.88M 10-Q · filed 2021-08-06 | $41.65M derived: sum of 3 quarters · filed 2022-08-08 | $53.67M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $12.70M 10-Q · filed 2022-05-06 | $16.02M 10-Q · filed 2021-05-06 | $28.43M derived: sum of 2 quarters · filed 2022-05-06 | $40.45M derived: sum of 3 quarters · filed 2022-05-06 | $50.91M derived: sum of 4 quarters · filed 2022-05-06 | |
| 2020-12-31 | $15.73M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $27.75M derived: sum of 2 quarters · filed 2021-11-05 | $38.22M derived: sum of 3 quarters · filed 2021-11-05 | $46.33M 10-K · filed 2021-02-26 | ||
| 2020-09-30 | $12.02M 10-Q · filed 2021-11-05 | $22.48M derived: sum of 2 quarters · filed 2021-11-05 | $30.59M 10-Q · filed 2021-11-05 | $45.59M derived: sum of 4 quarters · filed 2021-11-05 | ||
| 2020-06-30 | $10.46M 10-Q · filed 2021-08-06 | $18.57M 10-Q · filed 2021-08-06 | $33.57M derived: sum of 3 quarters · filed 2021-08-06 | $48.57M derived: sum of 4 quarters · filed 2021-08-06 | ||
| 2020-03-31 | $8.11M 10-Q · filed 2021-05-06 | $23.11M derived: sum of 2 quarters · filed 2021-05-06 | $38.11M derived: sum of 3 quarters · filed 2021-05-06 | $53.12M derived: sum of 4 quarters · filed 2021-05-06 | ||
| 2019-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $30.00M derived: sum of 2 quarters · filed 2021-02-26 | $45.01M derived: sum of 3 quarters · filed 2021-02-26 | $56.31M 10-K · filed 2021-02-26 | ||
| 2019-09-30 | $15.00M 10-Q · filed 2020-11-03 | $30.01M derived: sum of 2 quarters · filed 2020-11-03 | $41.32M 10-Q · filed 2020-11-03 | $55.10M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2019-06-30 | $15.01M 10-Q · filed 2020-08-06 | $26.32M 10-Q · filed 2020-08-06 | $40.10M derived: sum of 3 quarters · filed 2021-02-26 | $55.06M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2019-03-31 | $11.31M 10-Q · filed 2020-05-08 | $25.09M derived: sum of 2 quarters · filed 2021-02-26 | $40.06M derived: sum of 3 quarters · filed 2021-02-26 | $52.77M derived: sum of 4 quarters · filed 2021-02-26 | ||
| 2018-12-31 | $13.78M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $28.75M derived: sum of 2 quarters · filed 2021-02-26 | $41.46M derived: sum of 3 quarters · filed 2021-02-26 | $53.53M 10-K · filed 2021-02-26 | ||
| 2018-09-30 | $14.97M 10-Q · filed 2019-11-07 | $27.68M derived: sum of 2 quarters · filed 2019-11-07 | $39.75M 10-Q · filed 2019-11-07 | $55.19M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-06-30 | $12.72M 10-Q · filed 2019-08-06 | $24.78M 10-Q · filed 2019-08-06 | $40.22M derived: sum of 3 quarters · filed 2020-02-28 | $55.54M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2018-03-31 | $12.07M 10-Q · filed 2019-05-03 | $27.51M derived: sum of 2 quarters · filed 2020-02-28 | $42.83M derived: sum of 3 quarters · filed 2020-02-28 | $54.90M derived: sum of 4 quarters · filed 2020-02-28 | ||
| 2017-12-31 | $15.44M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $30.76M derived: sum of 2 quarters · filed 2020-02-28 | $42.83M derived: sum of 3 quarters · filed 2020-02-28 | $58.81M 10-K · filed 2020-02-28 | ||
| 2017-09-30 | $15.32M 10-Q · filed 2018-11-05 | $27.39M derived: sum of 2 quarters · filed 2018-11-05 | $43.37M 10-Q · filed 2018-11-05 | |||
| 2017-06-30 | $12.07M 10-Q · filed 2018-08-03 | $28.05M 10-Q · filed 2018-08-03 | ||||
| 2016-12-31 | $46.55M 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |